Lower EDIC May Improve Local Tumor Control in Lung CancerByEyub Akdemir, MDNovember 5th 2025Decreasing the low-dose bath of proton therapy to the body may limit the impact of radiation on lymphocytes and affect tumor response.
EDIC Displays Continuous Evolution as Variable in EOT Grade 3 LymphopeniaByEyub Akdemir, MDNovember 4th 2025According to Eyub Akdemir, MD, reducing EDIC may be feasible without compromising target coverage to reduce anticipated lymphopenia rates.